Abbreviations: COX = cyclo-oxgenase; IGF = insulin-like growing factor; IGFBP= insulin-like growth factor binding protein; NSCLC = non-small confined apartment lung cancer Cyclo-oxygenase (COX)-2 is repeatedly overexpressed in non-small cell lung cancer (NSCLC) Previous studies have implicated a number of cytokines and sprouting factors in the regulation of COX-2 expression.

Abbreviations: COX = cyclo-oxgenase; IGF = insulin-like growing factor; IGFBP= insulin-like growth factor binding protein; NSCLC = non-small confined apartment lung cancer

Cyclo-oxygenase (COX)-2 is repeatedly overexpressed in non-small cell lung cancer (NSCLC) Previous studies have implicated a number of cytokines and sprouting factors in the regulation of COX-2 expression, and COX-2 itself modulates the expression of a variety of gene (1-5) Our previous studies display that prostaglandin E2, the major production of COX-2 activity, suppresses the T-cell-mediated immunity in lung cancer. (67) In addition to its issues on cell-mediated immunity, tumor overexpression of COX-2 appears to be involved in enhanced invasion, promotion of angiogenesis, and resistance to apoptosis. (8-11) Thus, there is mounting evidence indicating the importance of COX-2 in NSCLC However, the knowledge about the changes in gene expression caused from the overexpression of COX-2 in NSCLC is fragmentary. In order to elucidate the COX-2-induced changes in NSCLC we have bearinged a microarray study using the Human Cancer Specific GeneChip (Affymetrix; Santa Clara, CA). In our research we compared the expression of approximately 1700 gene in the human lung adenocarcinoma small cavity line A549, transduced with COX-2 to A549 enclosed spaces with either no or real little COX-2 expression. As a consequence we have determined that the A549 solitary abode; squalids of high COX-2 content expres lower plains of insulin-like growth factor binding protein (IGFBP)-3 courier RNA and, as determined through IGFBP-3 enzyme-linked immunosorbent assay, lower on a levels of free soluble IGFBP-3 protein. Thus, the amount of unrestrained soluble A549 inversely correlated with the expression horizontal of COX-2. Previous studies have shown that IGFBP-3 antagonizes the mitogenicity of insulin-like growing factor (IGF)-1 and IGF-2. (1213) In addition, IGFBP-3 also has an IGF-independent tumor suppressor activity. (14-16) Therefore, we hypothesize that COX-2-induced suppression of IGFBP-3 in lung cancer enclosed spaces is one of the proper states leading to increased tumorigenicity. This is the first reflection to implicate IGFBP-3 as a gene modulated through COX-2 overexpression in cancer cells

REFERENCES

(1) Hayashi Y Kobayashi M Kuwata H et al. Interferon-[gamma] and interleukin 4 inhibit interleukin 1 beta-induced delayed prostaglandin E(2) generation between the sides of suppression of cyclooxygenase-2 expression in human fibroblasts. Cytokine 2000; 12:603-612

(2) Huang ZF Massey JB Via DP Differential regulation of cyclo-oxygenase-2 (COX-2) mRNA stability through interleukin-1 [beta] (IL-1 [beta]) and tumor necrosis factor-[alpha] (TNF-[alpha]) in human in vitro differentiated macrophages. Biochem Pharmacol 2000; 59:187-194

(3) Saha D Datta PK Sheng H et al. Synergistic induction of cyclo-oxygenase-2 by dint of transforming growth factor-[beta]1 and epidermal extension factor inhibits apoptosis in epithelial small rooms Neoplasia 1999; 6:508-517

(4) Fong CY Pang L Holland E et al. TGF-[beta]1 stimulates IL-8 release, COX-2 expression, and PGE(2) release in human airway polished muscle cells. Am J Physiol Lung lonely dwelling Mol Physiol 2000; 279:201-207

(5) Sato T Nakajima H Fujio K et al. Enhancement of prostaglandin E2 production by the agency of epidermal growth factor requires the coordinate activation of cytosolic phospholipase A2 and cyclo-oxygenase-2 in human squamous carcinoma A431 small rooms Prostaglandins 1997; 53:355-369

(6) Stolina M Sharma s Lin Y, et al. Specific inhibition of cyclo-oxygenase-2 restores antitumor reactivity according to altering the balance of IL-10 and IL-12 synthesis. J Immunol 2000; 164:361-370

(7) Huang M Stolina M Sharma s et al. Non-small cell lung cancer cyclo-oxygenase-2-dependent regulation of cytokine balance in lymphocyte and macrophages: up-regulation of interleukin-10 and down-regulation of interleukin-12 production. Cancer Re 1998; 58:1208-1216

(8) Tsujii M DuBois RN Alterations in cellular adhesion and apoptosis in epithelial lonely dwellings overexpressing prostaglandin endoperoxide synthase 2 lonely dwelling 1995; 83:493-501

(9) Ding XZ Tong WG Adrian TE Blockade of cyclo-oxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer confined apartments Anticancer Res 2000:20:2625-2631

(10) Masferrer JL Leahy KM Koki AT, et al. Antiangiogenic and antitumor activities of cyclo-oxygenase-2 inhibitors. Cancer Re 2000; 60:1306-1311

(11) Liu XH Kirschenbaum A, Yao s et al. Inhibition of cyclooxygenase-2 suppresse angiogenesis and the extension of prostate cancer in vivo. J Urol 2000; 164:820-825

(12) Grimberg A, Cohen P character of insulin-like growth factors and their binding proteins in extension control and carcinogenesis. J enclosed space Physiol 2000; 183:1-9

(13) Baxter RC Insulin-like produce factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am J Physiol Endocrinol Metab 2000; 278:967-976

(14) point aimed at AJ, Firth SM, King MA, et al. Insulin-like putting out factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer lonely dwellings J Biol Chem 2000; 275:39174-39181

...